ILDONG HOLDINGS CO.,LTD
000230 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000230003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시
- Website:
- https://www.ildongholdings.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 129.0 KB | ||
| 2025-09-11 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 44.3 KB | ||
| 2025-08-26 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-07-30 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB | ||
| 2025-07-30 00:00 |
M&A Activity
[기재정정]타법인주식및출자증권처분결정
|
Korean | 21.5 KB | ||
| 2025-07-30 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 15.8 KB | ||
| 2025-07-28 00:00 |
Report Publication Announcement
결산실적공시예고(안내공시)
|
Korean | 4.1 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 136.0 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 50.2 KB | ||
| 2025-06-23 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 17.1 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1015.5 KB | ||
| 2025-05-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-05-12 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB |
Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for ILDONG HOLDINGS CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye
GENIL
Türkiye
GENIL
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark
GMAB
Denmark
GMAB
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea
225220
South Korea
225220
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea
314130
South Korea
314130
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland
GMT
Poland
GMT
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea
066830
South Korea
066830
Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.
France
SIGHT
France
SIGHT
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway
GENT
Norway
GENT
Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.
United States of America
GERN
United States of America
GERN
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America
GILD
United States of America
GILD